Tianjin TEDA Biomedical Engineering Company Limited (stock code: 08189) announced its monthly return on movements in securities for November 2025, indicating no change in both authorized and issued share capital. The authorized share capital remains at RMB 213,390,000, divided into 1,436,400,000 H shares (RMB 0.1 par value each) and 697,500,000 domestic shares (RMB 0.1 par value each).

The total number of issued H shares remains at 1,436,400,000, and the number of domestic shares stands at 697,500,000. No treasury shares, options, warrants, convertible securities, or other arrangements were reported. The filing, submitted on 1 December 2025, confirms that all relevant dealings were authorized in accordance with applicable rules and regulations.